Madrigal Pharmaceuticals, Inc. (MDGL)

495.97 -9.26 (-1.83%) USD  |  NASDAQ  |  Jan 15, 16:00
495.97 0.00 (0.00%) After-Hours: 17:54
More

Madrigal Pharmaceuticals SG&A Expense (TTM): 715.08M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 10.39B
Amgen, Inc. 6.976B
Pfizer Inc. 13.91B
Crinetics Pharmaceuticals, Inc. 165.81M
Amicus Therapeutics, Inc. 353.07M